Location: Home
  • search
  • go
  • Relate News
  • 6/2/2022Zelixir Biotech Looks to Help Global Monkeypox Drug Development
  • 6/1/2022Xuanzhu and CTTQ-Akeso Tie Up to Develop Penpulimab for Solid Tumors
  • 6/1/2022Pharma Cos Accelerate Repositioning amid Rising Uncertainties and Macr...
  • 5/31/2022Rough Discussion On Experimental Data Submitted After Application Fili...
  • 5/31/2022CDE Issues the Technical Guidelines for Non-clinical Research and Asse...
  • 5/31/2022CDE Issues the Technical Guidelines for Pharmaceutical Studies and Eva...
  • 5/31/2022CDE Issues the Technical Guidelines for Pharmaceutical Studies and Eva...
  • 5/31/2022China to Expand Free HPV Vaccinations to Cover More People
  • 5/31/2022Recent Executive Moves
  • 5/31/2022Drug R&D and Product Registration News Digest May 2022 (4)
  • 5/31/2022Financial-related Company News Digest - May 2022
  • 5/30/2022CDE Issues the Technical Guidelines for Clinical Trials of Locally Adm...
  • 5/30/2022SMEI: Review of Chinese Retail Pharmacy Market (Offline and Online)
  • 5/27/2022GSK's 2-Dose HPV Vaccine Cervarix Wins Approval in China To Prevent Ce...
  • 5/27/2022NMPA Issues Chinese GMP's Clinical Trial Drug Appendix
  • 5/27/2022Shanghai Initiates Second Round of Budget Medical Insurance Scheme Huh...
  • 5/27/2022Tracking the Rise of CAR-Ts in China: The Dawn of An Immunotherapy Sup...
  • 5/26/2022China's First Decision In A Case Initiated Under Its Patent Linkage Sy...
  • 5/26/2022USTR Releases Special 301 Report On IP Protection With Special Section...
  • 5/26/2022April Licensing Trends Show Chinese Biotechs Expanding Beyond Oncology...
  • 5/26/2022Ten Trends of China's Pharmaceutical Industry in 2021 (PharmCube)
  • 5/26/2022Henlius and Abbott Enter Semi-Exclusive License Deal for Rituximab and...
  • 5/26/2022Data Snapshot: Top 20 Domestic Class 1 New Drugs by Sales in 2021
  • 5/26/2022Pharma Trading Platform Yaoshibang Applies for Hong Kong IPO
  • 5/25/2022CDE Issues the Technical Guidelines for Pharmaceutical Research and Ev...
  • 5/25/2022Hanmi Launches High-blood Pressure Drug Meiyaping (Amosartan) in China
  • 5/25/2022Beijing Health Chief Fired Following Investigation
  • 5/25/2022State Council Issues Notice on Major Tasks for Deepening Healthcare Re...
  • 5/25/2022Real-World Evidence Is Becoming a Pivotal Component in Chinese Healthc...
  • 5/24/2022New Draft Implementing Regulations Propose Key Changes for Pharmaceuti...
  • Page:139/775 Total number of articles:23243: [First][<<] [137] [138] [139] [140] [141] [>>] [End]
  • Site map | Contact Us | Links
  • © Wicon International Group